查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1722581

霍亂疫苗市場報告（按疫苗類型、產品、最終用戶和地區）2025-2033

Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球霍亂疫苗市場規模達 590 萬美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 1,360 萬美元，2025-2033 年期間的成長率 (CAGR) 為 9.6%。由於霍亂病例不斷增加（特別是在衛生條件差的地區）、全球各國政府的支持政策和資金不斷增加以及疫苗技術的不斷進步，市場正在穩步成長。

霍亂疫苗是一種旨在預防霍亂的醫療干預措施，霍亂是一種引起腹瀉並可能導致脫水甚至死亡的細菌感染。它們是使用去活化或減毒的霍亂弧菌（霍亂的病原體）組合研製而成的。該過程包括培養大量細菌，使其無毒，然後將其製成疫苗。霍亂疫苗的優點非常顯著，例如，它們提供了一種積極主動的方法來預防霍亂疫情，特別是在衛生設施和供水不足的地區。透過增強免疫系統識別和抵抗霍亂細菌的能力，這些疫苗可以減輕疾病的嚴重程度和持續時間。此外，它們還有助於減少霍亂在社區內和跨國的傳播。霍亂疫苗主要有兩種：口服疫苗和注射疫苗。

全球霍亂疫苗市場受到人們對霍亂預防和疫苗接種重要性的認知不斷提高的影響，尤其是在霍亂易發地區。此外，政府措施和國際組織透過疫苗接種運動控制霍亂傳播的努力在市場擴張中發揮關鍵作用。此外，疫苗技術的進步帶來了更有效率、更具成本效益的疫苗的開發，促進了市場的成長。此外，旅行和國際貿易頻率的增加促進了霍亂疫苗接種的需求，因為旅客有可能將霍亂攜帶跨境，這反過來又支持了市場的成長。除此之外，旨在提高疫苗功效和安全性的持續研發 (R&D) 活動也促進了市場的成長。

霍亂疫苗市場趨勢/促進因素：

提高認知與預防霍亂

隨著人們對霍亂預防和疫苗接種關鍵作用的認知不斷提高，全球霍亂疫苗市場得到了顯著推動。隨著社區越來越了解霍亂疫情的破壞性影響，對包括疫苗接種在內的有效預防措施的需求也增加。這種認知的提高往往受到公共衛生運動、教育活動和媒體報告的推動，這些活動強調了霍亂的後果以及接種疫苗對於遏制其傳播的重要性。這項驅動力不僅激發了個人和社區對疫苗接種的興趣，也鼓勵政府、醫療保健組織和國際機構為疫苗接種運動分配資源，推動市場成長。

政府措施和國際努力

政府舉措和國際組織的合作努力為全球霍亂疫苗市場的擴張做出了重大貢獻。霍亂易發地區的政府意識到霍亂帶來的社會經濟負擔，並將疫苗接種計畫列為重要的預防策略。此外，世界衛生組織（WHO）和聯合國兒童基金會等國際組織與各國政府建立合作關係，提供技術專長、資金和疫苗供應，以支持疫苗接種運動。這種協調一致的方法不僅確保了資源匱乏地區能夠獲得疫苗，而且還透過創造對霍亂疫苗的穩定需求，創造了有利於市場成長的環境。

疫苗技術的進步

疫苗技術的進步在推動全球霍亂疫苗市場發展方面發揮關鍵作用。隨著研發工作集中在提高疫苗的效力、安全性和生產流程，更新、更有效的霍亂疫苗被推向市場。這些進步使得發展出能夠提供更持久保護、所需劑量更少、適合更廣泛年齡層的疫苗成為可能。此外，疫苗輸送機制（如口服疫苗）的創新有助於提高疫苗的接受度和接種的便利性，特別是在醫療保健基礎設施有限的地區。疫苗技術的不斷發展不僅提高了霍亂疫苗的整體有效性，而且還透過為醫療保健提供者和社區提供更好的疾病預防工具來推動市場成長。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球霍亂疫苗市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依疫苗類型

  • 霍亂弧菌O1株及重組B亞基
  • 殺死口腔O1和O139

第7章：市場區隔：依產品

  • 杜科拉爾
  • 尚科爾
  • 瓦克斯喬拉
  • Euvichol 和 Euvichol-Plus
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院和診所
  • 研究和學術實驗室
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Astellas Pharma Inc.
    • Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
    • Emergent BioSolutions Inc.
    • Eubiologics Co. Ltd.
    • Johnson & Johnson
    • Merck & Co. Inc
    • Pfizer Inc.
    • PharmaChoice Canada Inc
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited.
    • Valneva SE
Product Code: SR112025A4973

The global cholera vaccines market size reached USD 5.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 13.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033. The market is experiencing steady growth driven by rising cholera cases, particularly in regions with poor sanitation and hygiene, the accelerating supportive government policies and funding across the globe, and continuous technological advancements in vaccine technology.

Cholera vaccines are medical interventions designed to provide protection against cholera, a bacterial infection that causes diarrhea and can lead to dehydration and even death. They are developed using a combination of inactivated or attenuated Vibrio cholerae bacteria, the causative agent of cholera. The process involves growing large quantities of the bacteria, rendering them non-virulent, and then formulating them into vaccines. The advantages of cholera vaccines are significant, such as they offer a proactive approach to preventing cholera outbreaks, particularly in regions with inadequate sanitation and water supplies. By bolstering the immune system's ability to recognize and fight the cholera bacteria, these vaccines can reduce the severity and duration of the illness. Moreover, they contribute to reducing the transmission of cholera within communities and across borders. Two main types of cholera vaccines include oral and injectable.

The global cholera vaccines market is influenced by the increasing awareness about cholera prevention and the importance of vaccination, especially in regions prone to outbreaks. Additionally, government initiatives and international organizations' efforts to control cholera's spread through vaccination campaigns play a pivotal role in market expansion. Moreover, advancements in vaccine technology, resulting in the development of more efficient and cost-effective vaccines, bolster market growth. Furthermore, the rising frequency of travel and international trade fosters the need for cholera vaccination, as travelers can potentially carry the disease across borders, which, in turn, is supporting the market growth. Besides this, ongoing research and development (R&D) activities aimed at enhancing vaccine efficacy and safety are contributing to the market growth.

Cholera Vaccines Market Trends/Drivers:

Increasing awareness and cholera prevention

The global cholera vaccines market experiences a significant impetus from the increasing awareness surrounding cholera prevention and the crucial role of vaccination. As communities become more informed about the devastating impact of cholera outbreaks, the demand for effective preventive measures, including vaccination, rises. This heightened awareness is often driven by public health campaigns, educational initiatives, and media coverage that highlight the consequences of cholera and the importance of vaccination in curbing its spread. This driver not only stimulates individual and community-level interest in vaccination but also encourages governments, healthcare organizations, and international bodies to allocate resources towards vaccination campaigns, propelling market growth.

Government initiatives and international efforts

Government initiatives and collaborative efforts by international organizations contribute significantly to the expansion of the global cholera vaccines market. Governments of cholera-prone regions recognize the socio-economic burden posed by cholera and prioritize vaccination programs as a crucial preventive strategy. Moreover, international organizations like the World Health Organization (WHO) and UNICEF engage in partnerships with governments, providing technical expertise, funding, and vaccine supply to support vaccination campaigns. This coordinated approach not only ensures vaccine accessibility in resource-constrained regions but also fosters a conducive environment for market growth by creating a steady demand for cholera vaccines.

Advancements in vaccine technology

Advancements in vaccine technology play a pivotal role in propelling the global cholera vaccines market forward. As research and development efforts focus on improving vaccine efficacy, safety, and production processes, newer and more effective cholera vaccines are introduced to the market. These advancements enable the creation of vaccines that offer longer-lasting protection, require fewer doses, and are suitable for a wider range of age groups. Additionally, innovations in vaccine delivery mechanisms, such as oral vaccines, contribute to increased vaccine acceptance and ease of administration, particularly in areas with limited healthcare infrastructure. The continuous evolution of vaccine technology not only enhances the overall effectiveness of cholera vaccines but also fuels market growth by providing healthcare providers and communities with better tools for disease prevention.

Cholera Vaccines Industry Segmentation:

Breakup by Vaccine Type:

  • Whole Cell V. Cholerae O1 with Recombinant B-Subunit
  • Killed Oral O1 and O139

Whole cell V. cholerae O1 with recombinant B-subunit dominates the market

The whole cell V. cholerae O1 with recombinant B-subunit segment is propelled by the comprehensive protection offered by whole-cell vaccines against cholera caused by V. cholerae O1. The inclusion of recombinant B-subunit enhances immunogenicity, bolstering the vaccine's efficacy in inducing protective immune responses. Additionally, the rising global awareness about cholera's impact on public health underscores the importance of advanced vaccines. Moreover, governmental initiatives and collaborations with international health organizations amplify the distribution and administration of these vaccines, especially in endemic regions. In line with this, ongoing research and development efforts continually refine vaccine formulations, ensuring optimal safety and effectiveness. Apart from this, the evolving landscape of international travel and trade heightens the demand for robust preventive measures, boosting the adoption of this segment.

Breakup by Product:

  • Dukoral
  • Shanchol
  • Vaxchora
  • Euvichol and Euvichol-Plus
  • Others

Dukoral dominates the market

The dukoral segment is propelled by the surging awareness regarding the unique formulation of the product, encompassing both cholera and ETEC (enterotoxigenic Escherichia coli) antigens. Additionally, its established reputation for safety and efficacy, backed by rigorous clinical trials, instills confidence among healthcare professionals and recipients alike, boosting its adoption. Moreover, the expanding travel and tourism sector drives demand for dukoral, as it addresses the risk of cholera and ETEC infections associated with global mobility. Furthermore, its oral administration aligns with the preference for non-invasive vaccination methods, especially in regions with limited healthcare infrastructure. In line with this, ongoing research to refine dukoral's formulation and increase accessibility in underserved areas underscores its significance, solidifying its position as a driver in the market's growth trajectory.

Breakup by End User:

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others

Hospitals and clinics dominate the market

The hospitals and clinics segment dominates the market due to the increasing demand for quality healthcare services and medical interventions. Hospitals and clinics serve as primary access points for medical care, catering to a wide range of medical needs from routine check-ups to specialized treatments. Additionally, advancements in medical technology and treatments drive the need for modern and well-equipped healthcare facilities. Patients seek out hospitals and clinics that offer cutting-edge diagnostic and treatment options, thus encouraging the growth of this segment. Moreover, the growing aging population contributes significantly to the demand for healthcare services. As elderly individuals require more frequent medical attention, hospitals and clinics play a crucial role in providing geriatric care. Furthermore, the rise in chronic diseases necessitates ongoing medical care and management, prompting a greater reliance on hospitals and clinics for continuous patient support.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North American cholera vaccines market is stimulated by a solid healthcare framework and an emphasis on disease prevention, with stringent public health policies and high awareness increasing demand. International travel and trade further necessitate vaccination. In Asia Pacific, rising cholera outbreaks, lack of sanitation, government efforts, population density, and tourism focus attention on vaccination. Europe's market is propelled by strong healthcare systems and proactive disease surveillance, while travel and trade accentuate the requirement for vaccination. Latin America's growth is due to uneven access to sanitation and government campaigns. In the Middle East and Africa, erratic sanitation infrastructure and recurring cholera outbreaks necessitate vaccines, with governmental and international efforts addressing waterborne diseases.

Competitive Landscape:

The competitive landscape within the market for cholera vaccine is characterized by a dynamic interplay of various factors that shape the positioning of key players. Market participants engage in a multitude of strategies to gain a competitive edge, including product innovation, strategic collaborations, geographical expansion, and mergers and acquisitions. The quest to capture larger market shares and establish brand prominence drives companies to invest in research and development, aiming to offer novel solutions that cater to evolving consumer needs. Furthermore, the emphasis on customer-centric approaches and effective marketing strategies is pivotal in differentiating brands in a crowded marketplace. Regulatory compliance and adherence to industry standards also contribute to the competitive dynamics. The competitive landscape is ever evolving, with players continuously adapting to market trends, customer preferences, and technological advancements to maintain their relevance and sustain growth in this competitive arena.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Astellas Pharma Inc.
  • Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
  • Emergent BioSolutions Inc.
  • Eubiologics Co. Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer Inc.
  • PharmaChoice Canada Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Valneva SE

Key Questions Answered in This Report

  • 1.What was the size of the global cholera vaccines market in 2024?
  • 2.What is the expected growth rate of the global cholera vaccines market during 2025-2033?
  • 3.What are the key factors driving the global cholera vaccines market?
  • 4.What has been the impact of COVID-19 on the global cholera vaccines market?
  • 5.What is the breakup of the global cholera vaccines market based on the vaccine type?
  • 6.What is the breakup of the global cholera vaccines market based on the product?
  • 7.What is the breakup of the global cholera vaccines market based on the end user?
  • 8.What are the key regions in the global cholera vaccines market?
  • 9.Who are the key players/companies in the global cholera vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cholera Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Whole Cell V. Cholerae O1 with Recombinant B-Subunit
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Killed Oral O1 and O139
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Dukoral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Shanchol
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Vaxchora
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Euvichol and Euvichol-Plus
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research and Academic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Astellas Pharma Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Emergent BioSolutions Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Eubiologics Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Johnson & Johnson
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 PharmaChoice Canada Inc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Valneva SE
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Cholera Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Cholera Vaccines Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Cholera Vaccines Market: Breakup by Vaccine Type (in %), 2024
  • Figure 5: Global: Cholera Vaccines Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Cholera Vaccines Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Cholera Vaccines Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Cholera Vaccines (Killed Oral O1 and O139) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cholera Vaccines (Killed Oral O1 and O139) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cholera Vaccines (Dukoral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cholera Vaccines (Dukoral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cholera Vaccines (Shanchol) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cholera Vaccines (Shanchol) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cholera Vaccines (Vaxchora) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cholera Vaccines (Vaxchora) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cholera Vaccines (Other Product) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cholera Vaccines (Other Product) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cholera Vaccines (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cholera Vaccines (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Cholera Vaccines (Research and Academic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Cholera Vaccines (Research and Academic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Cholera Vaccines (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Cholera Vaccines (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Cholera Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Cholera Vaccines Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Cholera Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Cholera Vaccines Industry: SWOT Analysis
  • Figure 78: Global: Cholera Vaccines Industry: Value Chain Analysis
  • Figure 79: Global: Cholera Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cholera Vaccines Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cholera Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
  • Table 3: Global: Cholera Vaccines Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Cholera Vaccines Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Cholera Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cholera Vaccines Market: Competitive Structure
  • Table 7: Global: Cholera Vaccines Market: Key Players